These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10394411)

  • 1. Cancer epidemiology and patient recruitment for hadron therapy.
    Engels H; Wambersie A
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():95-9. PubMed ID: 10394411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The med AUSTRON/OGRO patterns of care study on radiotherapy indications in Austria.
    Mock U; Mayer R; Potter R; Jäger R; Vutuc C; Eiter H; Hammer J; Hawliczek R; Hirn B; Knocke-Abulesz TH; Kogelnik HD; Lukas P; Nechville E; Pakisch B; Papauschek M; Ing Raunik W; Rhomberg W; Sabitzer H; Schratter-Sehn A; Sedlmayer F; Wedrich I; Auberger T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S29-34. PubMed ID: 15971305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.
    Black RJ; Bray F; Ferlay J; Parkin DM
    Eur J Cancer; 1997 Jun; 33(7):1075-107. PubMed ID: 9376190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO).
    Mayer R; Mock U; Jäger R; Pötter R; Vutuc C; Eiter H; Krugmann K; Hammer J; Hirn B; Hawliczek R; Knocke-Abulesz TH; Lukas P; Nechville E; Pakisch B; Papauschek M; Raunik W; Rhomberg W; Sabitzer H; Schratter-Sehn A; Sedlmayer F; Wedrich I; Auberger T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S24-8. PubMed ID: 15971304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ENLIGHT: European network for Light ion hadron therapy.
    Dosanjh M; Amaldi U; Mayer R; Poetter R;
    Radiother Oncol; 2018 Jul; 128(1):76-82. PubMed ID: 29625810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy infrastructure and human resources in Europe - present status and its implications for 2020.
    Datta NR; Samiei M; Bodis S
    Eur J Cancer; 2014 Oct; 50(15):2735-43. PubMed ID: 25085229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits.
    Coebergh JW; van den Hurk C; Louwman M; Comber H; Rosso S; Zanetti R; Sacchetto L; Storm H; van Veen EB; Siesling S; van den Eijnden-van Raaij J
    Eur J Cancer; 2015 Jun; 51(9):1050-63. PubMed ID: 25934439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Portal imaging: the legal point of view].
    Martin P
    Bull Cancer Radiother; 1996; 83(4):414-7. PubMed ID: 9081348
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hadron therapy in carcinoma].
    Vobornik S; Dalagija F
    Med Arh; 2002; 56(4):229-32. PubMed ID: 12518541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress of the Proton-Ion Medical Machine Study (PIMMS).
    Bryant PJ
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():1-4. PubMed ID: 10394382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project.
    Bentzen SM; Heeren G; Cottier B; Slotman B; Glimelius B; Lievens Y; van den Bogaert W
    Radiother Oncol; 2005 Jun; 75(3):355-65. PubMed ID: 16086915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the 1st Med-AUSTRON Conference. Innsbruck, Austria. October 1997.
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():1-128. PubMed ID: 10428721
    [No Abstract]   [Full Text] [Related]  

  • 13. COST-ENLIGHT strategic workshop on hadron (particle) therapy, CERN, Geneva, 3-4 May 2007.
    Taylor RE
    Br J Radiol; 2008 Mar; 81(963):169-71. PubMed ID: 18208851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comprehensive cancer monitoring programme in Europe.
    Bray F; Guerra Yi M; Parkin DM
    Eur J Public Health; 2003 Sep; 13(3 Suppl):61-6. PubMed ID: 14533751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformal radiation therapy with hadron beams and the programs of the TERA Foundation.
    Amaldi U
    Rays; 1998; 23(3):486-507. PubMed ID: 9932467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The present and future of heavy charged particle therapy].
    Tsujii H
    Nihon Rinsho; 1996 Jan; 54(1):268-73. PubMed ID: 8587201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of medical physics of Med-Austron.
    Haverkamp U
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():4-7. PubMed ID: 10394383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer in the European Community and its member states.
    Jensen OM; Estève J; Møller H; Renard H
    Eur J Cancer; 1990; 26(11-12):1167-256. PubMed ID: 2150000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.
    Borras JM; Lievens Y; Barton M; Corral J; Ferlay J; Bray F; Grau C
    Radiother Oncol; 2016 Apr; 119(1):5-11. PubMed ID: 26922487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risk diversity in non-western migrants to Europe: An overview of the literature.
    Arnold M; Razum O; Coebergh JW
    Eur J Cancer; 2010 Sep; 46(14):2647-59. PubMed ID: 20843493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.